Key points are not available for this paper at this time.
Abstract Background WHO Tuberculosis (TB) screening guidelines recommend computer-aided detection (CAD) software for chest radiograph (CXR) interpretation. However, studies evaluating their diagnostic and prognostic accuracy are limited. Methods We conducted a prospective cohort study of household TB contacts in South Africa. Participants all underwent baseline CXR and sputum investigation (routine single spontaneous and enhanced additionally 2-3 induced sputum investigation and passive and active follow-up for incident TB. CXR were processed comparing 3 CAD softwares (CAD4TBv7.0, qXRv3.0.0, and Lunit INSIGHT CXR 3.1.4.111). We evaluated their performance to detect routine and enhanced prevalent, and incident TB, comparing the performance to blood-based biomarkers (Xpert MTB host-response, Erythrocyte Sedimentation Rate, C-Reactive Protein, QuantiFERON) in a subgroup. Findings 483 participants were followed-up for 4.6 years (median). There were 23 prevalent (7 routinely diagnosed) and 38 incident TB cases. The AUC ROC to identify prevalent TB for CAD4TB, qXR and Lunit INSIGHT CXR were 0.87 (95% CI 0.77-0.96), 0.88 (95% CI 0.79-0.97) and 0.91 (95% CI 0.83-0.99) respectively. >30% with scores above recommended CAD thresholds who were bacteriologically negative on routine baseline sputum were subsequently diagnosed by enhanced baseline sputum investigation or during follow-up. The AUC performance of baseline CAD to identify incident cases ranged between 0.60-0.65. The diagnostic performance of CAD for prevalent TB was superior to blood-based biomarkers. Interpretation Our findings suggest that the potential of CAD-CXR screening for TB is not maximised as a high proportion of those above current thresholds but with a negative routine confirmatory sputum have true TB disease that may benefit intervention. Funding UKRI-MRC Summary We found that the diagnostic accuracy of CAD-CXR to identify prevalent TB cases in household TB contacts was high but >30% with scores above recommended CAD thresholds who were bacteriologically negative on routine testing baseline were subsequently diagnosed suggest that the potential of CAD-CXR screening is not maximised.
Building similarity graph...
Analyzing shared references across papers
Loading...
Liana Macpherson
MRC Clinical Trials Unit at UCL
Sandra V. Kik
Foundation for Innovative New Diagnostics
Matteo Quartagno
MRC Clinical Trials Unit at UCL
University College London
Imperial College London
Rutgers, The State University of New Jersey
Building similarity graph...
Analyzing shared references across papers
Loading...
Macpherson et al. (Mon,) studied this question.
synapsesocial.com/papers/68e61f51b6db6435875b19a5 — DOI: https://doi.org/10.1101/2024.06.30.24309731
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: